Thu, May 5, 2022
Wed, May 4, 2022
Tue, May 3, 2022
Mon, May 2, 2022
Sun, May 1, 2022
Fri, April 29, 2022

Vamil Divan Maintained (AXSM) at Strong Buy with Decreased Target to $49 on, May 3rd, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-49-on-may-3rd-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Vamil Divan of Mizuho, Maintained "Axsome Therapeutics, Inc." (AXSM) at Strong Buy with Decreased Target from $51 to $49 on, May 3rd, 2022.

Vamil has made no other calls on AXSM in the last 4 months.



There are 3 other peers that have a rating on AXSM. Out of the 3 peers that are also analyzing AXSM, 1 agrees with Vamil's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Vikram Purohit of "Morgan Stanley" Maintained at Hold with Decreased Target to $27 on, Wednesday, April 27th, 2022


These are the ratings of the 2 analyists that currently disagree with Vamil


  • Chris Howerton of "Jefferies" Maintained at Strong Buy with Increased Target to $77 on, Tuesday, March 29th, 2022
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Decreased Target to $50 on, Wednesday, March 2nd, 2022

Publication Contributing Sources